Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
In terms of science and technology, we work toward the development of precision and personalized medicines that target the basic defect of cystic fibrosis. We are exploring how the federal government may support these efforts through partnership and funding.Read more
Rodrigo Arancibia · Acting Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Improving access to precision medicines for Canadians with cystic fibrosis and other rare diseases.Read more
In terms of science and technology, we work toward the development of precision and personalized medicines that target the basic defect of cystic fibrosis. We are exploring how the federal government may support these efforts through partnership and funding.
Increased federal investment in health-related research.
David Lee · Chief Regulatory Officer, Health Canada (HC)
Increased federal investment in health-related research.Read more
Improving access to precision medicines for Canadians with cystic fibrosis and other rare diseases.
In terms of science and technology, we work toward the development of precision and personalized medicines that target the basic defect of cystic fibrosis. We are exploring how the federal government may support these efforts through partnership and funding.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.